Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Apply
HLX22 & Trastuzumab, Chemotherapy
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step